Analysts weigh in on banks, insurers, and asset managers as fresh market commentary shapes expectations across the financial services sector.
Carriage Services reaffirms 2026 EPS midpoint guidance after reporting its second-quarter results, signaling confidence in its full-year outlook.
U.S. Treasury yields declined as traders weighed the possibility of a diplomatic resolution to the Iran conflict, lifting demand for riskier assets.
Jeff Bezos confirms selling $1 billion in Amazon stock each year to fund Blue Origin, calling it his most important work.
Disney reports Q3 2026 earnings before the bell. Here’s what analysts expect on streaming, parks, and EPS.
Israeli runtime security startup Oligo raises $60m in Series B funding to expand its open-source and cloud application protection platform.
A $1,000 stake in gold, Bitcoin, or $TRUMP on January 20 tells a divergent story of political risk, crypto volatility, and safe-haven demand.
StreamElements, once a rising force in live-streaming tools, has laid off staff and scaled back operations as its business model failed to convert.
Major airlines are restoring and expanding Israel routes ahead of summer 2025, betting on a sharp rebound in travel demand to Tel Aviv.
MongoDB has announced it will report second-quarter fiscal 2027 earnings in August, drawing close attention from investors tracking its cloud database growth.
Lifetime Brands posts Q2 2026 results amid tariff headwinds, with management outlining cost mitigation strategies and cautious full-year guidance.
Immunovant’s Q1 2027 earnings call highlighted pipeline progress, reduced operating losses, and advancing clinical data for its FcRn inhibitor platform.
Nutex Health reported improved Q2 2026 financials, with rising revenue and a return to net profitability as patient volumes grew.
CoreWeave, Nebius, Lumentum, and Applied Materials headline a busy earnings week for AI infrastructure and semiconductor stocks.
Braveheart Bio prices its upsized IPO above expectations, raising over $200 million as investor appetite for biotech listings holds firm.
U.S. Treasury yields declined as traders weighed the possibility of a diplomatic resolution to the Iran conflict, lifting demand for riskier assets.
A $1,000 stake in gold, Bitcoin, or $TRUMP on January 20 tells a divergent story of political risk, crypto volatility, and safe-haven demand.
A prominent tech analyst argues Tesla’s autonomous driving and AI infrastructure make it far more than an automaker.
Rosen Law Firm is investigating Gildan Activewear for potential securities fraud, urging GIL investors to explore their legal options.
A structural gap in how Israeli and American founders build their first budgets is emerging as a key obstacle to global competitiveness.
Israeli startup QuantiHealth raises $45m to expand its AI platform that simulates clinical trials, cutting drug development time and cost.
Major airlines are restoring and expanding Israel routes ahead of summer 2025, betting on a sharp rebound in travel demand to Tel Aviv.
Trump and Republican allies are branding Democrats as communists amid a progressive policy push, deepening America’s political and economic divide.
The Bank of England will release its rate decision at 12:02 p.m. on Thursday to observe VE Day’s two minutes of silence.
Michigan’s 2026 Senate primary has become a flashpoint for Democratic infighting, with progressive and establishment wings clashing over the party’s direction.
An Ohio office building once valued at $17 million sold for just $2 million, raising fresh concerns about Israeli investors’ US commercial property exposure.
Two-bedroom granny pods and small backyard apartments are gaining traction as cost-effective housing solutions and income-generating assets.
Experts project U.S. mortgage rates will remain elevated through the decade, with 30-year fixed rates unlikely to fall below 6% before 2030.
